Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/1999
01/19/1999US5861487 Genetic sequences encoding flavonoid pathway enzymes and uses therefor
01/19/1999US5861485 Polypeptides involved in body weight disorders, including obesity
01/19/1999US5861484 Treatment of psoriasis, rheumatoid arthritis, hemangiomas, angiofibromas, diabetic retinopathy, neovascular glaucoma,and other vegf-induced pathological angiogenesis and vascular permeability conditions, such as tumor vascularization
01/19/1999US5861482 Genetic mapping
01/19/1999US5861480 Capable of isolation from seeds of aralia or impatiens exhibit antifungal and antibacterial activity
01/19/1999US5861378 Polypeptides having specified amino acid sequences; antiseptics, effective against grampositive and gramnegative bacteria
01/19/1999US5861377 Antistasin type serine protease inhibitors
01/19/1999US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes
01/19/1999US5861312 Recognition component; hybridization; dna expression vectors; genetic engineering
01/19/1999US5861310 Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
01/19/1999US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes
01/19/1999US5861308 Isolated nucleic acids associated with T cell activation and uses thereof
01/19/1999US5861307 Liposomes embedded with dna; antitumor agents; apotosis
01/19/1999US5861300 Plant transformation vector which comprises a nucleotide sequence which encodes an amino acid sequence having 2-5a-dependent rnase activity
01/19/1999US5861299 Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals
01/19/1999US5861295 Thermostable enzymes, such as dna polymerases and restriction endonucleases, that are substantially free from contamination with nucleic acids are produced by permeabilizing a thermophilic bacterial cell to form a spheroplast using a
01/19/1999US5861293 Glycosylate indolopyrrolocarbazole derivatives conveniently and economically
01/19/1999US5861290 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders
01/19/1999US5861288 Catalytic DNA
01/19/1999US5861285 Fusion dna sequence, obtained by fusing a gene coding for another useful protein to a fragment of a maga gene coding for a protein bound to an organic membrane for covering magnetic particles produced in cells of a magnetic bacterium amb-1
01/19/1999US5861284 Method for producing a biologically active recombinant cysteine-free parathyroid hormone (1-34)
01/19/1999US5861283 DNA encoding a limbic system-associated membrane protein
01/19/1999US5861282 Mutant constructs; vaccines; genetic engineering
01/19/1999US5861281 Lacc
01/19/1999US5861280 Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production
01/19/1999US5861279 Using peanut agglutinin as lectin in scintillation proximity assay
01/19/1999US5861277 Exogenous protein expression in plants and cells, vectors, dna fusion and polynucleotides also introns for genomes, seeds and plant food
01/19/1999US5861276 CDNAS encoding murine antibody against human plasma apolipoprotein B-100
01/19/1999US5861275 Lantibiotic mutants and chimeras of enhanced stability and activity, leader sequences therefor, genes encoding the same, and methods of producing and using the same
01/19/1999US5861274 Nucleic acids encoding peroxisome proliferator-activated receptor
01/19/1999US5861273 Inserting a copy of a gene encoding the heterologous protein of interest into the chromosome of a host cell
01/19/1999US5861271 Binding domain having amino acid sequence corresponding to that of a cellulase from trichoderma
01/19/1999US5861267 Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity
01/19/1999US5861259 Immunoassays for human cyclin E
01/19/1999US5861258 Use of the alpha interferon receptor and cells which express the receptor, for identification of alpha interferon agonists
01/19/1999US5861252 Method of analysis or assay for polynucleotides and analyzer or instrument for polynucleotides
01/19/1999US5861250 Protecting nucleic acids and methods of analysis
01/19/1999US5861240 Isolated human herpesvirus type 8 sequences and uses thereof
01/19/1999US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto
01/19/1999US5861161 Chimeric proteins comprising a Vpr/Vpx virion incorporation domain for targeting into HIV-1 or HIV-2 virions
01/19/1999US5861160 Vaccines for swine; epitope amino acid sequences; genetic engineering
01/19/1999US5861157 An immunogenic fragment obtained from a bacterial protein capable of eliciting antibody response
01/19/1999US5861155 Humanized antibodies and uses thereof
01/19/1999US5861151 Soluble fusion molecules with binding specificity for cell adhesion molecules
01/19/1999US5861150 Recombinant human CSF-1 dimer and compositions thereof
01/19/1999CA2139552C Use of self-incompatibility receptor proteins (slg and srk) of plants for the treatment of allergic diseases
01/19/1999CA2105382C Recombinant hybrid porin epitopes
01/19/1999CA2093152C Integrative gene-expression in food-grade microorganisms
01/19/1999CA2025900C Derivative of tissue-type plasminogen activator
01/19/1999CA2013573C Vaccines containing avirulent phop-type microorganisms
01/19/1999CA2004632C Expression induction method
01/19/1999CA1340327C Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
01/19/1999CA1340324C Plants with modified stamen cells
01/19/1999CA1340323C Rna catalyst for cleaving specific rna sequences
01/19/1999CA1340322C Human papillomavirus type 41, its dna and the proteins encoded therefrom
01/18/1999CA2237160A1 Gida1
01/18/1999CA2237147A1 Novel ratb
01/18/1999CA2237143A1 Novel rata
01/18/1999CA2237140A1 Novel tarf
01/18/1999CA2237050A1 Histidine kinase
01/18/1999CA2237043A1 Response regulator
01/17/1999CA2237162A1 Novel glucose kinase
01/16/1999CA2237784A1 Novel compounds
01/15/1999CA2220849A1 A human pelota homolog
01/14/1999WO1999001940A1 Biological data
01/14/1999WO1999001582A1 Screening methods using an atpase protein from a virus of the flaviviridae family
01/14/1999WO1999001579A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal
01/14/1999WO1999001578A1 Assaying nucleotides in solution using a fluorescent intensity quenching effect
01/14/1999WO1999001574A1 Method for diagnosing alzheimer disease
01/14/1999WO1999001572A2 Methods for rapidly detecting methicillin resistant staphylococci
01/14/1999WO1999001571A2 Compositions and methods for detecting vancomycin resistant enterococci by cycling probe reactions
01/14/1999WO1999001565A1 Method for increasing secretion of proteins in eukaryotic host cells
01/14/1999WO1999001563A1 Plasmids for plant transformation and method for using the same
01/14/1999WO1999001562A1 Protein producing cell containing multiple copies of a desired gene and a screenable marker but no selection marker
01/14/1999WO1999001561A1 IMPROVED PROCESS FOR THE PRODUCTION OF β-LACTAMS
01/14/1999WO1999001560A1 Vertebrate telomerase genes and proteins and uses thereof
01/14/1999WO1999001559A1 Novel mapk kinase
01/14/1999WO1999001558A1 Plant genes and polypeptides and uses thereof
01/14/1999WO1999001557A1 Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy
01/14/1999WO1999001556A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES
01/14/1999WO1999001555A1 Genes for niemann-pick type c disease
01/14/1999WO1999001554A1 Mammalian secretory peptide-9
01/14/1999WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them
01/14/1999WO1999001552A1 Fluorescent proteins as cell-type specific reporter
01/14/1999WO1999001551A2 Novel inhibitor of cellular proliferation
01/14/1999WO1999001549A1 Transcriptional activators with graded transactivation potential
01/14/1999WO1999001548A2 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
01/14/1999WO1999001547A1 Cloning and characterization of a human adenylyl cyclase
01/14/1999WO1999001546A1 Cloning and characterization of a human adenylyl cyclase
01/14/1999WO1999001545A1 STARCH CONVERSION PROCESS USING THERMOSTABLE ISOAMYLASES FROM $i(SULFOLOBUS)
01/14/1999WO1999001542A1 IKK-β PROTEINS, NUCLEIC ACIDS AND METHODS
01/14/1999WO1999001541A1 IKK-α PROTEINS, NUCLEIC ACIDS AND METHODS
01/14/1999WO1999001539A1 A process for purification of pcr test samples
01/14/1999WO1999001476A1 CRYSTAL STRUCTURES OF ANTI-FACTOR IX Fab FRAGMENTS AND METHODS OF USE FOR PEPTIDOMIMETIC DESIGN
01/14/1999WO1999001475A2 Human antibody against a fusion (poly) peptide or protein presenting a part having at least six histidines
01/14/1999WO1999001474A1 Methods for the isolation of proteinase inhibitor proteins from potato tubers
01/14/1999WO1999001473A2 Anti-bacterial methods and materials
01/14/1999WO1999001471A1 Nik proteins, nucleic acids and methods
01/14/1999WO1999001466A1 Secreted proteins and polynucleotides encoding them
01/14/1999WO1999001464A1 Componds and methods for treating and screening viral reactivation